Ashley H. Shoemaker, MD, MSCI (she/her/hers)

Associate Professor
Vanderbilt University Medical Center
Nashville, Tennessee, United States

Disclosure information not submitted.

Presentation(s):

• SAT-529 - Continuous Glucose Monitors Detect Hyperglycemia in Males with Duchenne Muscular Dystrophy

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-706 - Administration and Efficacy of Setmelanotide for Bardet Biedl Syndrome in Routine Clinical Practice

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SUN-541 - Continuous Glucose Monitoring Overestimated Hyperglycemia in A Non-Ambulatory Adult with Duchenne Muscular Dystrophy

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-688 - Long-Term Reductions of Hyperphagia with Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-689 - Efficacy and Safety of Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal in Prader-Willi Syndrome (PWS) (Study C614)

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-723 - Weight Category Improvement Following Setmelanotide in Patients with Acquired Hypothalamic Obesity

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• MON-690 - Impact of Long-Term Diazoxide Choline Extended Release (DCCR) Treatment and the Prader-Willi Syndrome Profile Questionnaire (PWSP)

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• ORF44-02 - Impact of Long-Term Diazoxide Choline Extended Release (DCCR) Treatment and the Prader-Willi Syndrome Profile Questionnaire (PWSP)

  Monday, June 15, 2026
  9:35 AM - 9:40 AM CT

• ORF44-05 - Long-Term Efficacy with Setmelanotide in Patients with Acquired Hypothalamic Obesity

  Monday, June 15, 2026
  10:00 AM - 10:15 AM CT